Pathstone Family Office’s Sanofi SNY Stock Holding History

Pathstone Family Office’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$834K	Buy	15,550 +5,815	+60%	+$310K	0.01%	800
2023 Q2	$542K	Buy	9,735 +3,325	+52%	+$179K	0.01%	720
2023 Q1	$361K	Sell	6,410 -23,514	-79%	-$1.14M	0.01%	833
2022 Q4	$995K	Buy	29,924 +8,304	+38%	+$364K	0.01%	798
2022 Q3	$839K	Buy	21,620 +13,129	+155%	+$585K	0.01%	832
2022 Q2	$425K	Buy	8,491 +3,674	+76%	+$195K	0.01%	646
2022 Q1	$258K	Sell	4,817 -342	-7%	-$17.7K	0.01%	805
2021 Q4	$258K	Sell	5,159 -432	-8%	-$21.4K	0.01%	755
2021 Q3	$269K	Buy	5,591 +927	+20%	+$47.1K	0.01%	711
2021 Q2	$246K	Buy	+4,664	New	+$243K	0.01%	707
2021 Q1	–	Sell	-645	Closed	-$31K	–	1252
2020 Q4	$31K	Sell	645 -409	-39%	-$20.2K	﹤0.01%	602
2020 Q3	$53K	Buy	1,054 +409	+63%	+$21.1K	0.01%	362
2020 Q2	$33K	Buy	+645	New	+$31.3K	﹤0.01%	366
2018 Q2	–	Sell	-227	Closed	-$9K	–	307
2018 Q1	$9K	Buy	+227	New	+$9.45K	0.01%	238
2017 Q3	–	Sell	-712	Closed	-$34K	–	316
2017 Q2	$34K	Hold	712	–	–	0.01%	238
2017 Q1	$32K	Buy	+712	New	+$30.2K	0.02%	210
2013 Q3	–	Sell	-64	Closed	-$3K	–	409
2013 Q2	$3K	Buy	+64	New	+$3.41K	﹤0.01%	318

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Pathstone Family Office's SNY Position: Q3 2023 in Review

Pathstone Family Office increased its Sanofi (SNY) stake by 60% in Q3 2023, buying an estimated $310K and bringing the position to 15,550 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #800.

Pathstone Family Office first reported a position in SNY in Q2 2013 and has held it in 17 quarters since. The position peaked at $995K in Q4 2022. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

Pathstone Family Office held 15,550 shares of Sanofi worth $834K as of Q3 2023.
Pathstone Family Office bought 5,815 Sanofi shares in Q3 2023, an estimated $310K.
Sanofi made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #800 holding.
Pathstone Family Office first reported a position in Sanofi in Q2 2013 and has held it in 17 quarters since.
Pathstone Family Office's Sanofi position peaked at $995K in Q4 2022.
696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.